Home > Insider Trading > Filing (0001209191-14-018066)

Filing Details

Accession Number:: 0001209191-14-018066
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-06 19:03:35
Reporting Period:: 2014-03-05

Filing Date:: 2014-03-06
Accepted Time:: 2014-03-06 19:03:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1360463	Larry Dillaha	444 South Ellis Street Chandler AZ 85224	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-05	18,750	$10.89	21,875	No	4	M	Direct
Common Stock	Acquisiton	2014-03-05	19,056	$3.54	40,931	No	4	M	Direct
Common Stock	Acquisiton	2014-03-05	112,126	$1.83	153,057	No	4	M	Direct
Common Stock	Disposition	2014-03-05	97,789	$72.65	55,268	No	4	S	Direct
Common Stock	Disposition	2014-03-05	537	$84.72	54,731	No	4	S	Direct
Common Stock	Disposition	2014-03-05	653	$83.92	54,078	No	4	S	Direct
Common Stock	Disposition	2014-03-05	624	$82.55	53,454	No	4	S	Direct
Common Stock	Disposition	2014-03-05	4,680	$81.91	48,774	No	4	S	Direct
Common Stock	Disposition	2014-03-05	5,717	$80.25	43,057	No	4	S	Direct
Common Stock	Disposition	2014-03-05	3,811	$79.81	39,246	No	4	S	Direct
Common Stock	Disposition	2014-03-05	2,304	$78.59	36,942	No	4	S	Direct
Common Stock	Disposition	2014-03-05	17,863	$77.24	19,079	No	4	S	Direct
Common Stock	Disposition	2014-03-05	15,954	$76.25	3,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-03-05	18,750	$0.00	18,750	$10.89
Common Stock	Stock Option (right to buy)	Disposition	2014-03-05	19,056	$0.00	19,056	$3.54
Common Stock	Stock Option (right to buy)	Disposition	2014-03-05	112,126	$0.00	112,126	$1.83

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
81,250	2023-05-13	No	4	D	Direct
29,944	2022-12-26	No	4	D	Direct
0	2020-04-04	No	4	D	Direct

Footnotes

Includes 3,125 shares acquired by the Reporting Person on December 11, 2013 pursuant to the Issuer's Employer Stock Purchase Plan.
The weighted average sales price for the transaction reported was $84.72, and the range of prices were between $84.40 and $85.00.
The weighted average sales price for the transaction reported was $83.92, and the range of prices were between $83.38 and $84.27.
The weighted average sales price for the transaction reported was $82.55, and the range of prices were between $82.14 and $83.00.
The weighted average sales price for the transaction reported was $81.91, and the range of prices were between $81.12 and $82.12.
The weighted average sales price for the transaction reported was $80.25, and the range of prices were between $80.09 and $80.93.
The weighted average sales price for the transaction reported was $79.81, and the range of prices were between $79.08 and $80.08.
The weighted average sales price for the transaction reported was $78.59, and the range of prices were between $78.00 and $79.00.
The weighted average sales price for the transaction reported was $77.24, and the range of prices were between $76.92 and $77.84.
The weighted average sales price for the transaction reported was $76.25, and the range of prices were between $75.90 and $76.90.
The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.
The option vests in 36 equal monthly installments and will be fully vested and exercisable on December 27, 2015.
The option is fully vested and exercisable.